• MARCH 14, 2019
    • 0
    FDA Takes New Steps To Broaden Patient Participation In Cancer Clinical Trials

    FDA Takes New Steps To Broaden Patient Participation In Cancer Clinical Trials

    “Some cancers are now being referred to as chronic diseases due to the advent of new cancer treatments.  In turn, this means we need to re-evaluate generic protocol inclusion/exclusion criteria. As you may know, inclusion/exclusion criteria are some of the rules by which patients are accepted into or excluded from a clinical trial. Improvements like

    Read more
    • FEBRUARY 4, 2019
    • 0

    Sickle-Cell Disease & What Might Have Cured Them

    Dr. Barry H. Kaplan’s response to the NY Times article titled “These Patients Had Sickle-Cell Disease. Experimental Therapies Might Have Cured Them.” Written by: Gina Kolata Nothing shows the astounding progress we are making in medicine more than a January 26th article in The New York Times. Sickle cell anemia is a dreadful disease. It

    Read more
    • OCTOBER 1, 2018
    • 0

    Nobel Prize Awarded to 2 Cancer Immunotherapy Researchers

    Dr. Barry H. Kaplan’s response to the article in The New York Times regarding the article titled: 2018 Nobel Prize in Medicine Awarded to 2 Cancer Immunotherapy Researchers   I was thrilled to see the 2018 Nobel Prize in Medicine given to two scientists who have had an outstanding impact on the whole field of

    Read more
    • JANUARY 15, 2017
    • 0

    Rising cost of diabetes care concerns patients and doctors

    Health cardio tellus fin amet intend morbi consectetur adipiscing forte. Nullam volutpat rutrum mode technical maecenas a velit ornare. Pharetra interdum libero vitae novum at fiber. Mauris etos vitae turpis interdum pulvinar mode nisi malesuada consectetur fusce libero est cuprum. Node gravida et elit sed auctor novum donec blandin laoreet rhoncus a risum novec convallis.

    Read more